Blog
Hybrid financing in life sciences: Unlocking growth amid market challenges
Life sciences companies and investors continue to navigate a complex and challenging investment landscape – marked by high interest rates, a volatile regulatory environment, tight venture capital (VC) markets, and slowly rebounding initial public offering (IPO) activity….
By: McDermott Will & Schulte